OR WAIT null SECS
November 02, 2013
The JOBS Act and FDASIA show early signs of accelerating drug development.
October 02, 2013
Ireland?s life-sciences sector has grown significantly since the 1960s. To gain insights into the competitive edge that Ireland offers to the pharmaceutical industry, Pharmaceutical Technology Europe spoke with Barry Heavey from IDA Ireland, which is a government agency responsible for attracting pharmaceutical and biotech companies to Ireland.
Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.
September 02, 2013
There has been a notable shift in interest for life-science companies over recent months from institutional investors investing through the public markets, but any plans to release further capital will rely on first-rate R&D.
PDA/FDA regulatory conference promotes a commitment to quality.
August 02, 2013
As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.
August 01, 2013
Orphan drugs for rare diseases are a major area of investment for pharmaceutical companies, but are they becoming too expensive for Europe to afford them?
July 02, 2013
Pharma and biotech companies, with the rest of the health care industry, must face change.
July 01, 2013
As the dreaded patent cliff continues to haunt the pharmaceutical industry, some companies are resorting to desperate measures to delay generic drug entry into the market.
June 02, 2013
With downsizing occurring more frequently than ever within the pharmaceutical industry, is Europe doing enough to curb further job losses that could threaten the recovery of its economy?